Emergence of daptomycin non-susceptible coagulase-negative Staphylococci in patients with cardiovascular device infections: Two cases report investigated by whole genome analysis

RATIONALE: Daptomycin (DAP) is a key drug for treating severe Staphylococcus infections. The emergence of DAP non-susceptible Staphylococcus aureus has been widely recognized in clinical situations, although the clinical status of DAP non-susceptible coagulase-negative Staphylococcus (CoNS) infectio...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Medicine (Baltimore)
Main Authors: Hagiya, Hideharu, Sugawara, Yo, Kimura, Keigo, Hamaguchi, Shigeto, Nishi, Isao, Hayashi, Masahiro, Akeda, Yukihiro, Tomono, Kazunori
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Health 2018
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6310605/
https://ncbi.nlm.nih.gov/pubmed/30544442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000013487
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki